Cargando…
Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1
BACKGROUND: Gene therapy has recently shown considerable clinical benefit in cancer therapy during the past few years, and the application of this choice in cancer treatments is increasing continually. Gli1 is an ideal candidate target for cancer gene therapy and is important for tumorigenesis. METH...
Autores principales: | Zhou, Peizhi, Cao, Yue, Liu, Xiaoxiao, Yu, Ting, Xu, Qian, You, Chao, Gao, Xiang, Wei, Yuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118331/ https://www.ncbi.nlm.nih.gov/pubmed/30214189 http://dx.doi.org/10.2147/IJN.S164364 |
Ejemplares similares
-
Local siRNA delivery by non-viral vectors
por: Beilvert, F., et al.
Publicado: (2012) -
Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
por: Liu, Hong-Mei, et al.
Publicado: (2017) -
Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018) -
Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006) -
Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)